MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis
Jinho Jung(University of California, Irvine), Egbert Madamba(University of California San Diego), Atsushi Nakajima(Yokohama City University), Claude B. Sirlin(University of California San Diego), Kento Imajo(University of California San Diego), Rohit Loomba(University of California San Diego), Carolyn Hernandez(University of California San Diego), Mark A. Valasek(Sharp Memorial Hospital), Ricki Bettencourt(University of California San Diego), Cynthia Behling(Johns Hopkins University), Seema Singh(University of California San Diego), Sanil Gandhi(Boston University), Lisa Richards(University of California San Diego), Katie Fowler(University of California San Diego), Rohan Loomba(University of California San Diego)
Cited by 155
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k